{"transactions":[{"id":4634555,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-10-02T02:49:08.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":97.24,"value":80806.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":666078,"source":{"system":"sec-edgar","filing":"0001783108-26-000034","document":"form4-10012026_101004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000034/form4-10012026_101004.xml","form_type":"4"}},{"id":4625605,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-09-23T21:07:59.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":800,"price":95.0968,"value":76077.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $94.94 and the highest price at which shares were sold was $95.51. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":666909,"source":{"system":"sec-edgar","filing":"0001783108-26-000032","document":"form4-09232026_090954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000032/form4-09232026_090954.xml","form_type":"4"}},{"id":4625604,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-09-23T21:07:59.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":23135,"price":94.4044,"value":2184045.794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $93.93 and the highest price at which shares were sold was $94.92. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":667709,"source":{"system":"sec-edgar","filing":"0001783108-26-000032","document":"form4-09232026_090954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000032/form4-09232026_090954.xml","form_type":"4"}},{"id":4625603,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-09-23T21:07:59.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":9065,"price":93.368,"value":846380.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $92.93 and the highest price at which shares were sold was $93.92. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":690844,"source":{"system":"sec-edgar","filing":"0001783108-26-000032","document":"form4-09232026_090954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000032/form4-09232026_090954.xml","form_type":"4"}},{"id":458,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-09-02T20:14:03.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6326,"price":92.56,"value":585534.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":699909,"source":{"system":"sec-edgar","filing":"0001783108-26-000030","document":"form4-09022026_080959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000030/form4-09022026_080959.xml","form_type":"4"}},{"id":677461,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-08-24T21:31:36.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":3411,"price":88.6813,"value":302491.9143,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $88.58 and the highest price at which shares were sold was $88.94. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":706235,"source":{"system":"sec-edgar","filing":"0001783108-26-000028","document":"form4-08242026_090832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000028/form4-08242026_090832.xml","form_type":"4"}},{"id":677460,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-08-24T21:31:36.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":22789,"price":88.2536,"value":2011211.2904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $87.58 and the highest price at which shares were sold was $88.575. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":709646,"source":{"system":"sec-edgar","filing":"0001783108-26-000028","document":"form4-08242026_090832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000028/form4-08242026_090832.xml","form_type":"4"}},{"id":677459,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-08-24T21:31:36.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":6300,"price":87.2316,"value":549559.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $86.57 and the highest price at which shares were sold was $87.56. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":732435,"source":{"system":"sec-edgar","filing":"0001783108-26-000028","document":"form4-08242026_090832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000028/form4-08242026_090832.xml","form_type":"4"}},{"id":677458,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-08-24T21:31:36.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":500,"price":84.802,"value":42401.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $84.65 and the highest price at which shares were sold was $85.03. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":738735,"source":{"system":"sec-edgar","filing":"0001783108-26-000028","document":"form4-08242026_090832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000028/form4-08242026_090832.xml","form_type":"4"}},{"id":697254,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-08-04T22:48:03.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":74.71,"value":62084.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":739235,"source":{"system":"sec-edgar","filing":"0001783108-26-000026","document":"form4-08042026_100857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000026/form4-08042026_100857.xml","form_type":"4"}},{"id":718136,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-07-02T20:40:17.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":83,"value":68973.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":740066,"source":{"system":"sec-edgar","filing":"0001783108-26-000024","document":"form4-07022026_080713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000024/form4-07022026_080713.xml","form_type":"4"}},{"id":729180,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:52:35.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":2558,"price":70.89,"value":181336.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $70.36 and the highest price at which shares were sold was $71.34. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":740897,"source":{"system":"sec-edgar","filing":"0001783108-26-000022","document":"form4-06232026_080631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000022/form4-06232026_080631.xml","form_type":"4"}},{"id":729179,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:52:35.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":8507,"price":69.8247,"value":593998.7229,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $69.35 and the highest price at which shares were sold was $70.345. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":743455,"source":{"system":"sec-edgar","filing":"0001783108-26-000022","document":"form4-06232026_080631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000022/form4-06232026_080631.xml","form_type":"4"}},{"id":729178,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:52:35.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":21935,"price":68.9271,"value":1511915.9385,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $68.35 and the highest price at which shares were sold was $69.34. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":751962,"source":{"system":"sec-edgar","filing":"0001783108-26-000022","document":"form4-06232026_080631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000022/form4-06232026_080631.xml","form_type":"4"}},{"id":757111,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-06-01T23:10:44.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6326,"price":56.21,"value":355584.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":773897,"source":{"system":"sec-edgar","filing":"0001783108-26-000020","document":"form4-06012026_110640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000020/form4-06012026_110640.xml","form_type":"4"}},{"id":761953,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-05-27T23:14:57.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":55.1574,"value":60673.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $54.86 and the highest price at which shares were sold was $55.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":780223,"source":{"system":"sec-edgar","filing":"0001783108-26-000018","document":"form4-05272026_110553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000018/form4-05272026_110553.xml","form_type":"4"}},{"id":761952,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-05-27T23:14:57.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":5905,"price":54.287,"value":320564.735,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $53.85 and the highest price at which shares were sold was $54.81. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":781323,"source":{"system":"sec-edgar","filing":"0001783108-26-000018","document":"form4-05272026_110553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000018/form4-05272026_110553.xml","form_type":"4"}},{"id":761951,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-05-27T23:14:57.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":8995,"price":53.2927,"value":479367.8365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $52.85 and the highest price at which shares were sold was $53.84. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 781 shares of Class A Common Stock acquired by the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan."}],"balance_after":787228,"source":{"system":"sec-edgar","filing":"0001783108-26-000018","document":"form4-05272026_110553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000018/form4-05272026_110553.xml","form_type":"4"}},{"id":772170,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-05-20T01:19:35.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that was acquired through an exempt transaction with the Issuer.  Each RSU represents a right to receive one share of the Issuer's Class A Common Stock at the time of vesting for no consideration."}],"balance_after":795442,"source":{"system":"sec-edgar","filing":"0001783108-26-000016","document":"form4-05202026_010532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000016/form4-05202026_010532.xml","form_type":"4"}},{"id":793905,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-05-04T20:07:38.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":44.6,"value":37062.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":730442,"source":{"system":"sec-edgar","filing":"0001783108-26-000014","document":"form4-05042026_080533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000014/form4-05042026_080533.xml","form_type":"4"}},{"id":822932,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-04-01T20:24:30.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":38.56,"value":32043.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":731273,"source":{"system":"sec-edgar","filing":"0001783108-26-000012","document":"form4-04012026_080425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000012/form4-04012026_080425.xml","form_type":"4"}},{"id":829417,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-03-24T23:35:04.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":2906,"price":42.7538,"value":124242.5428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $42.66 and the highest price at which shares were sold was $42.86. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":732104,"source":{"system":"sec-edgar","filing":"0001783108-26-000010","document":"form4-03242026_110300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000010/form4-03242026_110300.xml","form_type":"4"}},{"id":829416,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-03-24T23:35:04.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":9838,"price":42.3571,"value":416709.1498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $41.66 and the highest price at which shares were sold was $42.65. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":735010,"source":{"system":"sec-edgar","filing":"0001783108-26-000010","document":"form4-03242026_110300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000010/form4-03242026_110300.xml","form_type":"4"}},{"id":829415,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-03-24T23:35:04.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":2256,"price":41.2126,"value":92975.6256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $40.66 and the highest price at which shares were sold was $41.62. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":744848,"source":{"system":"sec-edgar","filing":"0001783108-26-000010","document":"form4-03242026_110300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000010/form4-03242026_110300.xml","form_type":"4"}},{"id":867710,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-03-03T22:27:08.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5127,"price":42.76,"value":219230.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":747104,"source":{"system":"sec-edgar","filing":"0001783108-26-000008","document":"form4-03032026_100302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000008/form4-03032026_100302.xml","form_type":"4"}},{"id":885094,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-02-24T21:21:39.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":308,"price":40.4599,"value":12461.6492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $40.45 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":752231,"source":{"system":"sec-edgar","filing":"0001783108-26-000006","document":"form4-02242026_090235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000006/form4-02242026_090235.xml","form_type":"4"}},{"id":885093,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-02-24T21:21:39.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":6818,"price":39.9476,"value":272362.7368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $39.45 and the highest price at which shares were sold was $40.44. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":752539,"source":{"system":"sec-edgar","filing":"0001783108-26-000006","document":"form4-02242026_090235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000006/form4-02242026_090235.xml","form_type":"4"}},{"id":885092,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-02-24T21:21:39.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":7874,"price":38.7553,"value":305159.2322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $38.435 and the highest price at which shares were sold was $39.41. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":759357,"source":{"system":"sec-edgar","filing":"0001783108-26-000006","document":"form4-02242026_090235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000006/form4-02242026_090235.xml","form_type":"4"}},{"id":922018,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-02-04T01:45:27.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1429,"price":34.9,"value":49872.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":767231,"source":{"system":"sec-edgar","filing":"0001783108-26-000004","document":"form4-02042026_010219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000004/form4-02042026_010219.xml","form_type":"4"}},{"id":951733,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2026-01-05T21:34:50.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1118,"price":46.45,"value":51931.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":768660,"source":{"system":"sec-edgar","filing":"0001783108-26-000002","document":"form4-01052026_090146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310826000002/form4-01052026_090146.xml","form_type":"4"}},{"id":959691,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-12-23T21:18:47.000Z","date":"2025-12-22","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":48.3967,"value":725950.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $47.785 and the highest price at which shares were sold was $48.74. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":769778,"source":{"system":"sec-edgar","filing":"0001783108-25-000011","document":"form4-12232025_091243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310825000011/form4-12232025_091243.xml","form_type":"4"}},{"id":985146,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-12-01T21:08:02.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5126,"price":48.91,"value":250712.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."}],"balance_after":784776,"source":{"system":"sec-edgar","filing":"0001783108-25-000009","document":"form4-12012025_091256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310825000009/form4-12012025_091256.xml","form_type":"4"}},{"id":990194,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:28:37.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":2954,"price":46.0885,"value":136145.429,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $46.01 and the highest price at which shares were sold was $46.21. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":789902,"source":{"system":"sec-edgar","filing":"0001783108-25-000007","document":"form4-11242025_091133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310825000007/form4-11242025_091133.xml","form_type":"4"}},{"id":990193,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:28:37.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":9332,"price":45.7528,"value":426965.1296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $45.01 and the highest price at which shares were sold was $46.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":792856,"source":{"system":"sec-edgar","filing":"0001783108-25-000007","document":"form4-11242025_091133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310825000007/form4-11242025_091133.xml","form_type":"4"}},{"id":990192,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:28:37.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":2714,"price":44.3538,"value":120376.2132,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $43.96 and the highest price at which shares were sold was $44.94. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":802190,"source":{"system":"sec-edgar","filing":"0001783108-25-000007","document":"form4-11242025_091133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310825000007/form4-11242025_091133.xml","form_type":"4"}},{"id":993905,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:52:56.000Z","date":"2025-11-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":15977,"price":40.84,"value":652500.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 781 shares of Class A Common Stock acquired by the Reporting Person on November 14, 2025 pursuant to the Issuer's employee stock purchase plan."}],"balance_after":804904,"source":{"system":"sec-edgar","filing":"0001783108-25-000005","document":"form4-11192025_091153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000178310825000005/form4-11192025_091153.xml","form_type":"4"}},{"id":1135445,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2025-05-23T21:21:25.000Z","date":"2025-05-23","kind":"other","planned":false,"acquired":true,"shares":820100,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, was reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, was reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 215,417 RSUs, which vest in accordance with the terms of the applicable awards. Each RSU represents a contingent right to receive one share of Class A Common Stock."}],"balance_after":820100,"source":{"system":"sec-edgar","filing":"0000950170-25-077107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000095017025077107/ownership.xml","form_type":"4"}},{"id":1135444,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-05-23T21:21:25.000Z","date":"2025-05-23","kind":"other","planned":false,"acquired":false,"shares":820100,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, was reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, was reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-077107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000095017025077107/ownership.xml","form_type":"4"}},{"id":1135443,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-05-23T21:21:25.000Z","date":"2025-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":445646,"price":32,"value":14260672.0,"ownership":{"direct":true},"balance_after":820100,"source":{"system":"sec-edgar","filing":"0000950170-25-077107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000095017025077107/ownership.xml","form_type":"4"}},{"id":1135442,"issuer":{"id":377,"kind":"organization","name":"Hinge Health, Inc.","symbol":"HNGE"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-05-23T21:21:25.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":96875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units (\"RSUs\"), which vests as to 3.125% of the total award each quarter for the first two years, and as to 9.375% of the total award each quarter thereafter until fully vested at the fourth anniversary of the vesting commencement date. Each RSU represents a contingent right to receive one share of Class A Common Stock following the reclassification of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities were previously reported on a Form 3 filed by the Reporting Person."}],"balance_after":1265746,"source":{"system":"sec-edgar","filing":"0000950170-25-077107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000095017025077107/ownership.xml","form_type":"4"}},{"id":2997499,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T21:21:59.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One-fourth of the shares subject to the option vested on June 19, 2019 and 1/48 of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.62,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001639225-20-000064","document":"wf-form4_160409289833502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000163922520000064/wf-form4_160409289833502.xml","form_type":"4"}},{"id":2997498,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T21:21:59.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-fourth of the shares subject to the option vested on December 4, 2018 and 1/48 of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.88,"expiration_date":"2027-12-03","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001639225-20-000064","document":"wf-form4_160409289833502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000163922520000064/wf-form4_160409289833502.xml","form_type":"4"}},{"id":2997497,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T21:21:59.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth of the shares subject to the option vested on November 16, 2017 and 1/48 of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.38,"expiration_date":"2026-11-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001639225-20-000064","document":"wf-form4_160409289833502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000163922520000064/wf-form4_160409289833502.xml","form_type":"4"}},{"id":2997496,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T21:21:59.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.8,"expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001639225-20-000064","document":"wf-form4_160409289833502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000163922520000064/wf-form4_160409289833502.xml","form_type":"4"}},{"id":2997495,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T21:21:59.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":105572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.8,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":105572},"source":{"system":"sec-edgar","filing":"0001639225-20-000064","document":"wf-form4_160409289833502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000163922520000064/wf-form4_160409289833502.xml","form_type":"4"}},{"id":2997494,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-10-30T21:21:59.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":73294,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 21,537 restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding RSU award of the Issuer was converted into a number of RSUs with respect to a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such RSU award immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (as defined below) (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), subject to the same terms and conditions as were applicable to such Issuer RSU immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000064","document":"wf-form4_160409289833502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000163922520000064/wf-form4_160409289833502.xml","form_type":"4"}},{"id":3037854,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"exercise","acquired":false,"shares":19428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":105572,"derivative":{"exercise_price":0.8,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":19428},"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037853,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"exercise","acquired":false,"shares":5429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.36,"expiration_date":"2024-12-11","underlying":"Common Stock","underlying_shares":5429},"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037852,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"sale","acquired":false,"shares":341,"price":129.0342,"value":44000.6622,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. (\"Teladoc\") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the \"Merger\"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019 (the \"Trading Plan\"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock and vested stock options held immediately prior to such sales."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.77 to $129.16, inclusive."}],"balance_after":73294,"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037851,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"sale","acquired":false,"shares":940,"price":127.9992,"value":120319.248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. (\"Teladoc\") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the \"Merger\"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019 (the \"Trading Plan\"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock and vested stock options held immediately prior to such sales."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.58 to $128.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."}],"balance_after":73635,"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037850,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"sale","acquired":false,"shares":12803,"price":124.51,"value":1594101.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. (\"Teladoc\") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the \"Merger\"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019 (the \"Trading Plan\"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock and vested stock options held immediately prior to such sales."}],"balance_after":74575,"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037849,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"sale","acquired":false,"shares":10773,"price":124.41,"value":1340268.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. (\"Teladoc\") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the \"Merger\"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019 (the \"Trading Plan\"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock and vested stock options held immediately prior to such sales."}],"balance_after":87378,"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037848,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"exercise","acquired":true,"shares":19428,"price":0.8,"value":15542.4,"ownership":{"direct":true},"balance_after":98151,"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3037847,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-05T01:14:27.000Z","date":"2020-09-04","kind":"exercise","acquired":true,"shares":5429,"price":0.36,"value":1954.44,"ownership":{"direct":true},"balance_after":78723,"source":{"system":"sec-edgar","filing":"0001209191-20-049683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120049683/doc4.xml","form_type":"4"}},{"id":3044681,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-28T20:21:42.000Z","date":"2020-08-26","kind":"sale","acquired":false,"shares":738,"price":132.53,"value":97807.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":73294,"source":{"system":"sec-edgar","filing":"0001209191-20-048626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120048626/doc4.xml","form_type":"4"}},{"id":3089095,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-06T21:21:06.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":7071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":5429,"derivative":{"exercise_price":0.36,"expiration_date":"2024-12-11","underlying":"Common Stock","underlying_shares":7071},"source":{"system":"sec-edgar","filing":"0001209191-20-041067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120041067/doc4.xml","form_type":"4"}},{"id":3089094,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-06T21:21:06.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.36,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001209191-20-041067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120041067/doc4.xml","form_type":"4"}},{"id":3089093,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T21:21:06.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":3300,"price":75.6476,"value":249637.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.365 to $76.08, inclusive."}],"balance_after":74032,"source":{"system":"sec-edgar","filing":"0001209191-20-041067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120041067/doc4.xml","form_type":"4"}},{"id":3089092,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T21:21:06.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":7039,"price":74.829,"value":526721.331,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.34 to $75.31, inclusive."}],"balance_after":77332,"source":{"system":"sec-edgar","filing":"0001209191-20-041067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120041067/doc4.xml","form_type":"4"}},{"id":3089091,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T21:21:06.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":14518,"price":73.8573,"value":1072260.2814,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.34 to $74.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":84371,"source":{"system":"sec-edgar","filing":"0001209191-20-041067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120041067/doc4.xml","form_type":"4"}},{"id":3089090,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T21:21:06.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":24857,"price":0.36,"value":8948.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."}],"balance_after":98889,"source":{"system":"sec-edgar","filing":"0001209191-20-041067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120041067/doc4.xml","form_type":"4"}},{"id":3132398,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-28T22:04:41.000Z","date":"2020-05-26","kind":"tax_withholding","acquired":false,"shares":346,"price":55,"value":19030.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."}],"balance_after":74032,"source":{"system":"sec-edgar","filing":"0001209191-20-032698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120032698/doc4.xml","form_type":"4"}},{"id":3145740,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-18T22:58:21.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":13805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units which vest in 16 equal quarterly installments beginning on August 25, 2020."}],"balance_after":74378,"source":{"system":"sec-edgar","filing":"0001209191-20-030241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120030241/doc4.xml","form_type":"4"}},{"id":3186817,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-02T20:50:53.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":24857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":17786,"derivative":{"exercise_price":0.36,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":24857},"source":{"system":"sec-edgar","filing":"0001209191-20-022624","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120022624/doc4.xml","form_type":"4"}},{"id":3186816,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-04-02T20:50:53.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":11200,"price":27.2128,"value":304783.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.14 to $27.39, inclusive."}],"balance_after":60573,"source":{"system":"sec-edgar","filing":"0001209191-20-022624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120022624/doc4.xml","form_type":"4"}},{"id":3186815,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-04-02T20:50:53.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":13657,"price":26.9302,"value":367785.7414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $27.138, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)  to this Form 4."}],"balance_after":71773,"source":{"system":"sec-edgar","filing":"0001209191-20-022624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120022624/doc4.xml","form_type":"4"}},{"id":3186814,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-04-02T20:50:53.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":24857,"price":0.36,"value":8948.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."}],"balance_after":85430,"source":{"system":"sec-edgar","filing":"0001209191-20-022624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120022624/doc4.xml","form_type":"4"}},{"id":3220749,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-09T22:10:10.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":24857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":42643,"derivative":{"exercise_price":0.36,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":24857},"source":{"system":"sec-edgar","filing":"0001209191-20-017449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120017449/doc4.xml","form_type":"4"}},{"id":3220748,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T22:10:10.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":9023,"price":27.964,"value":252319.172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.89 to $28.04, inclusive."}],"balance_after":60573,"source":{"system":"sec-edgar","filing":"0001209191-20-017449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120017449/doc4.xml","form_type":"4"}},{"id":3220747,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T22:10:10.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":14410,"price":27.5547,"value":397063.227,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.89 to $27.87, inclusive."}],"balance_after":69596,"source":{"system":"sec-edgar","filing":"0001209191-20-017449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120017449/doc4.xml","form_type":"4"}},{"id":3220746,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T22:10:10.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":1424,"price":26.3394,"value":37507.3056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.72 to\n$26.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnotes (2), (3) and (4) to this Form 4."}],"balance_after":84006,"source":{"system":"sec-edgar","filing":"0001209191-20-017449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120017449/doc4.xml","form_type":"4"}},{"id":3220745,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-09T22:10:10.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":24857,"price":0.36,"value":8948.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."}],"balance_after":85430,"source":{"system":"sec-edgar","filing":"0001209191-20-017449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120017449/doc4.xml","form_type":"4"}},{"id":3246558,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-02-26T21:33:27.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":271,"price":25.27,"value":6848.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."}],"balance_after":60573,"source":{"system":"sec-edgar","filing":"0001209191-20-013027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120013027/doc4.xml","form_type":"4"}},{"id":3304201,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-01-24T01:56:02.000Z","date":"2019-12-02","kind":"tax_withholding","acquired":false,"shares":222,"price":27.68,"value":6144.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":60844,"source":{"system":"sec-edgar","filing":"0001209191-20-004770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120004770/doc4.xml","form_type":"4"}},{"id":3304200,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-01-24T01:56:02.000Z","date":"2019-10-23","kind":"tax_withholding","acquired":false,"shares":234,"price":21.32,"value":4988.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":61066,"source":{"system":"sec-edgar","filing":"0001209191-20-004770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000120919120004770/doc4.xml","form_type":"4"}},{"id":3453352,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-07-30T20:35:32.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":48800,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0000899243-19-020585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000089924319020585/doc4.xml","form_type":"4"}},{"id":3453351,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":421,"kind":"person","name":"Pursley James","position":1,"cik":"0001783108","reported_name":"Pursley James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-07-30T20:35:32.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":48800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."}],"balance_after":61300,"source":{"system":"sec-edgar","filing":"0000899243-19-020585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783108/000089924319020585/doc4.xml","form_type":"4"}}]}